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Abstract: The photothermal effect is undergoing great interest due to advances in new 
photosensitizing materials and better-suited light sources, but studies are frequently hampered 
by the need to employ exogenous photothermal agents and expensive irradiation devices. 
Here we present a simple strategy based on direct NIR irradiation of the melanin pigment 
with a commercial 808-nm laser pointer. Proof-of-concept studies showed efficient 
photothermal effects on melanin in vitro and in vivo. After NIR irradiation, BALB/c mice 
bearing B16-F10 melanotic melanoma tumors revealed severe histopathological damage and 
massive necrosis in melanin-containing tumor tissue, while surrounding healthy tissues 
showed no damage. Therefore, the feasibility of this approach may allow implementing direct 
procedures for photothermal therapy of pigmented tumors. 
© 2019 Optical Society of America under the terms of the OSA Open Access Publishing Agreement 
1. Introduction 
Weakly pigmented people (Caucasians) have high incidence of skin melanoma [1,2]. In 
contrast, strongly pigmented human populations and African-Americans have fewer incidence 
of melanoma, which seems to be due to the protective effect of melanin against UV 
irradiation [3,4], although in these cases the disease appears more aggressive [5]. Obviously, 
experimental research in murine models involving melanotic cells is highly relevant to the 
biology and treatment of melanoma tumors in human patients. 
The murine melanoma B16, originated and growing in the C57BL/6 strain of black mice, 
is one of the most popular and extensively used tumor models in oncological research. In 
1980 Poste and Fidler isolated from it the established B16-F10 cell line featuring high 
metastatic capacity, which opened the broad field of subpopulations in the biology of 
metastasis [6]. It is known that murine cells and tissues from one strain are rejected by the 
immune system when inoculated in another strain (except in immunosuppressed mice). Thus, 
the melanoma B16-F10 from C57BL/6 mice is rejected by the immune system when 
inoculated in mice of the histo-incompatible strain, BALB/c [7], because the 
histocompatibility antigen (H2) of C57BL/6 is H2b, but that of BALB/c is H2d [8,9]. 
Recently, one of us (L.L.C.) obtained a transplanted form of the melanoma B16-F10. This 
new melanotic tumor has the capacity of growing in the subcutaneous tissue of white histo-
incompatible BALB/c mice, and is being subjected to further characterization. In the present 
work we decided to take advantage of this new transplanted melanoma, because it is one step 
closer to what happens in human patients, where melanotic tumors generally have high 
incidence (mainly in geographical areas with intensive sun radiation, like Arizona or 
Australia, with weakly pigmented populations) [1–5]. 
From a therapeutic point of view, it is well known that photodynamic (PDT) and 
photothermal therapy (PTT) are approved and currently applied clinical antitumor treatments 
using appropriate photosensitizers and red or near infrared (NIR) irradiation. Light absorption 
and scattering of most soft biological tissues are very low in the red to NIR spectral region 
(between 600 and 1300 nm), in the so-called biological (diagnostic and therapeutic) window, 
with the lowest absorption at 810-820 nm [10–12]. At present, NIR-laser irradiation finds 
many applications in different fields, mainly cosmetics (hair and tattoo removal, skin 
resurfacing, and photo-treatment of vascular-related disorders [13,14]). Ruby (694 nm), 
alexandrite (755 nm), diode (800-810 nm), and Nd:YAG (1064 nm) lasers are the most used 
light sources for photothermal melanin-based hair removal [15–18], and PTT of cancer [19–
24]. New NIR dyes and nanoparticles are also being investigated for biomedical imaging 
[25,26], as well as photothermal agents for PTT [27–31]. PTT is based on the local heat 
generation during light exposure. Thermal energy dissipation occurs from light-excited 
molecules by internal conversion and relaxation of vibrational energy levels, generating fast 
heating [32,33]. A key element in the photothermal effect is the efficient conversion of 
electronic excitation energy to vibrational energy and heat (Fig. 1). 
 
Fig. 1. Scheme illustrating the photothermal effect. The energy of NIR photons is absorbed by 
electrons in the valence band (VB) of photothermal polymers or nanoparticles, pumping them 
to the conduction band (CB). Electronic excitation leaves positive charges (holes) in the VB, 
and after a very short time, electrons and holes recombine due to their mutual electrostatic 
attraction, converting a great part of the absorbed energy in lattice vibrations (wiggly arrows) 
and thermal energy. 
In comparison with PDT, PTT has the advantage that it does not depend on O2 availability 
at the treated tumor, and only an efficient mechanism of fast light-to-heat conversion is 
necessary to induce a biological response. The photothermal effect (selective 
photothermolysis) was early applied by Anderson and Parrish [34] and Parrish et al. [35] on 
skin models, and relies on the selective absorption of brief laser pulses that generate and 
confine heat at certain pigmented cell and tissue targets by a radiation-less thermal decay. The 
laser pulse induces high temperature in the pigmented (absorbing) target, whereas no heating 
occurs in the surrounding tissue. In contrast, during a long irradiation heat transfer takes place 
and the entire tissue is damaged by coagulation necrosis [34,35]. 
In the last few years, carbon-based materials have been used to effectively generate a 
photothermal action on biological substrates, mainly experimental tumors [36]. We have 
recently reported that the pigment carbon black (CI: 77266) from China (Indian) ink is an 
efficient photothermal agent when injected to white mice tumors and irradiated with an 808-
nm laser [37]. On the premise that melanotic melanoma cells indeed contain melanin as an 
intrinsic black chromophore, and that the structural and optical features of this biopolymer are 
similar to carbon black-containing materials with a quasi-graphitic structure [36,38–40], we 
decided to assess the photothermal effects of this endogenous and readily available intrinsic 
pigment, mainly in melanoma cells. In addition, the present murine model (white skin) is very 
adequate because if NIR laser irradiation of melanotic melanomas growing in black mice is 
used, the otherwise normal, but absorbing skin would also be strongly affected. In this work, 
proof-of-concept demonstrations and an easy-to-implement setup are applied to show the 
direct photothermal effect on melanotic tumors using NIR irradiation from a commercial laser 
pointer [37]. 
2. Materials and methods 
2.1 NIR irradiation 
A portable NIR commercial laser pointer (model GLP-808, Changchun New Industries 
Optoelectronics Technology Co., Ltd., P. R. China) was used for irradiation of model 
substrates and mice tumors. Emission wavelength as provided by the supplier is 808 ± 3 nm. 
The emission is cw and the emitted power is ~200 mW as measured with a thermopile (LM-
10, Coherent Inc., USA). The beam diameter is ~1.2 mm which translates into an irradiance 
of ~17.68 Wcm−2. In all cases, the distance between the laser output and the different 
irradiated targets was kept constant at 10 cm. At this distance, the spot area of the laser beam 
was ~1.1 mm2. 
2.2 Spectra and model experiments in vitro 
Absorption spectra and photothermal assessment were done using sepiomelanin, which is 
analogous to the eumelanin from mammals [41]. Sepiomelanin is the eumelanin pigment 
isolated from the ink sac of cuttlefish (Sepia officinalis L.). Cuttlefish or sepia ink (Freiremar, 
Las Palmas de Gran Canaria, Spain) consists of a suspension of small, dark melanin-
containing granules in a colorless plasma. Absorption spectra were made with sepia ink 
diluted 1:2000 (v/v) with distilled water using a UV-VIS 1604 spectrophotometer (Shimadzu, 
USA). For comparative purposes, spectra of China ink (Pelikan black drawing ink Z, Pelikan 
AG, Hannover, Germany) diluted 1:2000 (v/v) with distilled water were also recorded. 
Kinetic measurements of ignition point and temperature increase were made using 
different concentrations of sepia ink and irradiation times. In the first case, white paper stripes 
were impregnated with different dilutions of sepia ink in distilled water, air dried and 
irradiated with the 808-nm laser, recording the time elapsed before ignition. Temperature 
increase of sepia ink was also assessed using a chemical thermometer (Franklin, Buenos 
Aires, Argentina) placed at 10 cm of the laser output. The thermometer bulb was surrounded 
first by a sleeve of paper strip impregnated with 50% sepia ink, covered with transparent 
adhesive tape to prevent evaporation and dryness of the paper, and then subjected to NIR 
irradiation. 
2.3 Melanotic tumor transplants 
Melanotic tumor transplants in white mice were carried out with inbred female BALB/c mice, 
2–4 months old, from the Breeding Area of the Institute of Oncology, kept in a temperature- 
(20 ± 2 °C) and light-controlled room with free access to water and dietary chow. Animal 
care was provided in full compliance with regulations for protection of animals at the 
Institute. 
Along of a previous tumoral research line, several white BALB/c mice were intended to 
be immunized against the allogeneic melanotic melanoma B16-F10 (from black C57BL/6 
mice) by subcutaneous (sc) injection of ~106 cultured cells. Unexpectedly, in one of the white 
mice, the black tumor grew up, without any sign of regression. Then pieces of about 1 mm3 of 
this tumor were transplanted (sc by trocar) in the flank of five BALB/c mice. Two mice never 
developed tumors, in other two cases tumors grew up but finally they regressed, and in one 
animal the tumor grew up without regression. From this mouse, black tumor pieces of about 1 
mm3 were transplanted again in the flank of other five BALB/c mice. As the transplanted 
melanomas are not homogeneous in pigmentation, only the more pigmented (black) regions 
were used to make the transplants. This procedure was repeated for several months, gradually 
increasing the percentage of mice without tumor regression. Currently, we are close to obtain 
the 100% of successful in tumor growth without regression. 
2.4 Photothermal tumor experiments 
Black tumors around 10 mm in diameter in BALB/c mice were subjected to control (no 
treatment, n = 2), and experimental protocols (NIR irradiation, n = 5). The overlying hair on 
tumors and surrounding skin regions was clipped, and before laser treatment, anesthesia was 
administrated by intraperitoneal injection of 0.2–0.3 mL of a solution of xylazine (20 mg/kg) 
and ketamine (50 mg/kg) in saline. Tumors were irradiated for 4, 6 and 10 min with the 808-
nm laser fixed to a metal frame to keep a constant distance to the target [37]. For an example 
of the experimental setup, with the position of the NIR laser pointer and a tumor-bearing 
mouse, readers are referred to Fig. 3(a) [37]. 
To reduce light scattering by keratin layers, a drop of glycerol was placed on the shaved 
skin covering the tumor area. In one case, a buttonhole was made in the skin over the tumor, 
and the tumor surface was then directly irradiated, thus avoiding the overlying white skin. 
Twenty-four hours after treatment, mice were sacrificed, and tumors resected, fixed in 10% 
buffered formalin for 24 h, and embedded in paraffin. Histological sections were stained with 
Gill’s II hematoxylin and eosin Y (H&E), observed and photographed under a light 
microscope (Zeiss Corp., Germany). 
3. Results and discussion 
3.1 In vitro photothermal experiments 
Mammalian melanosomes are spherical or ellipsoid granules about 0.5-1 µm with eumelanin 
as the major pigment [35]. Although the precise macromolecular organization of eumelanins 
is still controversial, there is consensus about their main chemical structure, which 
corresponds to linear indole-5,6-quinone and indole-5,6-quinone-2-carboxylic acid polymers 
(as well as 5,6-dihydroxy derivatives), with 4,7’ linkages and a high level of conjugated 
double bonds [41–46]. An example of linearly arranged indole-5,6-quinone (and 5,6-
dihydroxy)-2-carboxylic acid units from eumelanin is shown in Fig. 2(a). This biopolymer is 
capable of dissipating >99.9% of absorbed UV and visible radiation through non-radiative 
decay [47] and therefore, it is a very suitable photothermal agent. 
 
Fig. 2. (a) Chemical structure of eumelanin, according to recent overviews [41,46], showing 4 
units of the linear 4,7’-linked indole-5,6-quinone (and 5,6-dihydroxy)-2-carboxylic acid 
polymer, with atom numbering. (b) Comparative absorption spectra of sepia ink (A) and China 
ink (B), both diluted 1:2000 (v/v) with distilled water, showing the position of the 808-nm 
laser excitation (dashed line). The broad-band absorption curves decrease monotonically going 
from UV to NIR, a typical feature of these black polymeric chromophores. 
Sepia melanin revealed a broad-band and structure-less optical absorption spectrum with 
decreasing values from the UV to NIR regions (Fig. 2(b)), in agreement with previous 
observations [35,39]. Comparative absorption curves of sepia ink (A) and China ink (B) 
showed the same broad-band features, which are characteristic of unsaturated polymeric 
chromophores with high level of double bond conjugation [12,34,35,39]. Experiments 
regarding the ignition time of paper stripes impregnated with sepia ink at different 
concentrations, dried and then irradiated with 808-nm laser for different times showed a very 
rapid ignition of melanin spots (Fig. 3(a)). The average ignition temperature of paper is 230 
°C, and can be considered as a clear end point of the photothermal reaction. Likewise, 
kinetics of NIR-induced temperature increase of water and sepia ink also revealed striking 
differences. After 4 min 808-nm irradiation, the temperature of 50% sepia ink reached 58 °C, 
whereas that of water remained unchanged (Fig. 3(b)). Obviously, this large photothermal 
effect should generate a significant biochemical and mechanical tissue damage. 
 
Fig. 3. (a) Ignition time (seconds) of paper stripes impregnated with sepia ink at different 
concentrations (circles and squares). Papers were air dried, and then irradiated with 808-nm 
laser for different times. The higher the ink content, the faster the paper ignition. Note that 
even low ink concentration lead to ignition after 5 s, proof of its very high photothermal 
efficiency. (b) Temperature increase (in °C) of water (squares) and 50% sepia ink in water 
(circles) during 808-nm irradiation for different times (min). The temperature increases 
significantly for the sepia ink solution (58 °C at 4 min), while the temperature remains 
constant for water alone (26 °C at 4 min). 
3.2 In vivo photothermal experiments 
In histological H&E-stained sections, non-irradiated tumors from control animals showed the 
typical morphology of the B16-F10 melanotic melanoma, with large polyhedral cells 
containing a variable amount of melanosomes (Fig. 4(a)). Although the occurrence of melanin 
pigment in control sections was clearly observed within most cells from black tumor regions, 
big extracellular melanin deposits were also found. 
As expected from in vitro results, histopathological observations revealed that NIR 
irradiation induced a clear and extensive tissue damage, generally greater in tumor regions 
with large amounts of melanin. Sections of irradiated tumors showed massive necrosis, 
pycnotic nuclei, increased eosinophilia, severely disorganized stroma and edema, big and 
round brown-black melanophages, and disrupted tumor cells with release of melanin and 
cytoplasm fragments (Fig. 4(b)). Not only melanin-containing cells were damaged by NIR 
irradiation, but also neighboring cells (tumor cells with lesser or no melanosomes, stroma 
cells) appeared strongly damaged. This could represent a bystander effect due to the heat 
wave/mechanical wave (see below) affecting tumor regions near the melanin-containing laser 
target. However, scarce viable tumor cells showing mitosis were also observed. The degree of 
tissue damage was comparable after the different irradiation times used. Irradiation trough a 
skin buttonhole was also effective, and no appreciable differences were found compared with 
irradiation through the normal skin. In addition, the skin over the irradiated tumor area 
remained intact, without signs of cell damage. Blood vessels did not appear specifically 
damaged, and no hemorrhagic regions were observed within tumors. 
 
Fig. 4. Histological H&E images of the melanotic melanoma B16-F10 growing in BALB/c 
mice, (a) without irradiation (control tumor), and (b) after irradiation with the 808-nm laser for 
10 min and observed 24 h later. (a) Small and large black granules (melanosomes) appear 
within tumor cells, but sometimes they are located in the extracellular space (white arrows). 
The irradiated tumor section (b) shows extensive damaged and necrotic areas with rounded or 
disrupted tumor cells (white arrows), big brown-black melanophages (encircled), as well as 
pycnotic cell nuclei (black arrows), and cytoplasm fragmentation. Scale bars: 30 µm. 
Several experimental studies using NIR laser irradiation have been carried out on normal 
skin, and are widely applied for hair removal. As far as we know, attempts to treat melanotic 
melanomas directly by NIR laser irradiation have been rather overlooked, although the 
amelanotic melanoma B78-H1 cell line was sometimes applied in PTT studies using 
cyanines, naphthalocyanines and NIR irradiation [29,48]. In early studies using 351 nm-laser, 
degenerative and necrotic changes in normal melanin-containing human keratinocytes and 
disruption of melanosomes were observed [34]. It is well known that after strong and rapid 
heating by NIR laser pulses, protein coagulation causes “coagulation necrosis”, with 
subsequent hemostasis. The same process occurs by thermal diffusion during and after longer 
exposures to NIR irradiation [34,35]. It is known that tumor cells are more sensitive to a 
temperature increase than normal cells [49]. Currently, temperatures of 42-43 °C are 
considered lethal for tumor cells, and the smaller heat dissipation by impaired blood flow in 
tumors as compared to normal tissues contributes to thermal confinement and higher 
deleterious effect [50]. Interestingly, preliminary results showed that treatment of a non-
pigmented murine tumor with synthetic dopamine-melanin followed by NIR irradiation 
induced lethal photothermal effects [51]. 
Other causes of tissue damage by photothermal effects could be the explosive 
vaporization of melanosomes in situ with severe damage of pigmented skin [52,53], and 
photothermally-induced generation of acoustic shock waves [21]. This seems important in our 
experimental context, as the observed tumor damage pattern at the cellular level is fully 
compatible with photothermally-driven mechanical damage to the irradiated sample (see 
white arrows in Fig. 4(b)). That this was achieved with a moderate intensity (200 mW) cw 
laser, not a pulsed one, deserves special notice, in our opinion. Indeed, the photothermal 
action in our experiments reminds of the similar thermocavitation phenomenon, whereby a 
cw laser is capable of driving cycles of bubble inception-cavitation-collapse under conditions 
of moderate light absorption by the irradiated volume [54]. Furthermore, “popping” sounds 
were audible during melanotic tumor irradiation, presumably proof of thermal (micro-)bubble 
evolution and collapse during laser exposure. 
There are very few clinical trials about PTT and cancer (only 2 from 17,305), and no 
studies have been found in the case of melanoma tumors directly subjected to PTT protocols 
[55]. In addition to surgery, other therapeutical options for melanoma are now available (e.g., 
chemo-, radio-, immunotherapy, targeted therapy, PDT [56–58]), but further research and 
improved protocols are still necessary when pursuing the development and approval of new 
and more effective treatments for melanoma tumors and metastatic melanoma. As it also 
occurs in the case of PDT, the application of PTT is limited by the light penetration inside 
tissues, which is mainly due to light absorption and scattering. Although NIR irradiation 
penetrates deeper than visible light, tumors located in the depth of organs are difficult to be 
completely removed by these phototherapeutic procedures. Obviously, improvements such as 
NIR lasers with higher power and larger beam diameter must be achieved to increase the 
photothermal response of tumors. However, it has been our goal in this work to present a 
proof-of-concept procedure based in using melanin as an intrinsic chromophore within 
melanoma tumors, and direct irradiation with a cw 808-nm laser pointer to achieve a rapid, 
easy, and effective photothermal response. Interestingly, the photothermal treatment during or 
after surgical resection of melanotic tumors would be a suitable complement to remove some 
remaining tumor regions or scattered tumor cells. We hope that the presented methodology 
and results will allow further advances in the field of photothermal therapy. 
4. Conclusions 
Melanin is a very adequate infrared photothermal chromophore, and studies on model 
systems in vitro indicate that a very rapid and strong photothermal effect occurs in NIR-
irradiated sepiomelanin, with almost immediate ignition of dried samples and considerable 
temperature increase of aqueous solutions. Histopathological observations reveal that a 
massive necrosis of the tumor tissue appears in NIR-irradiated regions of the B16-F10 
melanotic melanoma successfully transplanted into white BALB/c mice. Taking into account 
our present results, the use of a cw 808-nm laser pointer as a light source supports the 
potential value of direct NIR irradiation for the therapy of pigmented skin tumors. 
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